ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,886.82
      -0.08%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Eyetech Pharmaceuticals (MM) (EYET)

      7. Eyetech Pharmaceuticals (MM) (EYET) News

      EYET

      Eyetech (EYET)

      Eyetech Pharmaceuticals (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:EYET
      DateTimeSourceHeadlineSymbolCompany
      11/12/20055:52PMBusiness WireOSI Pharmaceuticals and Eyetech Pharmaceuticals Confirm November 14th ClosingNASDAQ:EYETEyetech Pharmaceuticals (MM)
      11/10/200511:30AMPR Newswire (US)Eyetech Provides Update on Status of Pending Acquisition by OSI PharmaceuticalsNASDAQ:EYETEyetech Pharmaceuticals (MM)
      10/31/20055:00PMPR Newswire (US)Eyetech Reports Third Quarter 2005 Financial ResultsNASDAQ:EYETEyetech Pharmaceuticals (MM)
      10/17/20059:30AMPR Newswire (US)Eyetech Announces Enrollment of the First Patient in a Phase 3 Clinical Trial of Macugen(R) (pegaptanib sodium injection) in DiaNASDAQ:EYETEyetech Pharmaceuticals (MM)
      10/05/20059:30AMPR Newswire (US)Recent Analyses Suggest That Treatment With Macugen(R) (pegaptanib sodium injection) May Provide Better Results for Patients WitNASDAQ:EYETEyetech Pharmaceuticals (MM)
      09/16/20059:15AMPR Newswire (US)Macugen(R) (pegaptanib sodium injection) Receives Positive Opinion for Treatment of Neovascular Age-Related Macular DegenerationNASDAQ:EYETEyetech Pharmaceuticals (MM)
      08/21/20058:48PMPR Newswire (US)OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger AgreementNASDAQ:EYET
      08/21/20057:45PMBusiness WireOSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement; Acquisition Projected to be AccNASDAQ:EYETEyetech Pharmaceuticals (MM)
      08/09/20059:30AMPR Newswire (US)Macugen(R) (pegaptanib sodium injection) Named Innovative Pharmaceutical Product Of The Year At The 2005 Pharmaceutical AchievemNASDAQ:EYETEyetech Pharmaceuticals (MM)
      07/27/20055:30PMPR Newswire (US)Eyetech Reports Second Quarter 2005 Financial ResultsNASDAQ:EYETEyetech Pharmaceuticals (MM)
      07/18/20052:30PMPR Newswire (US)Eyetech and Pfizer Comment on Data Presented at Meeting of Retinal SpecialistsNASDAQ:EYET
      07/15/20051:30PMPR Newswire (US)Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005NASDAQ:EYETEyetech Pharmaceuticals (MM)
      06/22/20058:30AMPR Newswire (US)Eyetech Raises Full-Year Sales Forecast for Macugen(R) (pegaptanib sodium injection)NASDAQ:EYETEyetech Pharmaceuticals (MM)
      06/21/20053:33PMPR Newswire (US)Eyetech Vision Day to Preview Future of Macugen FranchiseNASDAQ:EYET
      06/13/20057:34PMPR Newswire (US)Eyetech to Host Vision Day on Wednesday, June 22NASDAQ:EYETEyetech Pharmaceuticals (MM)
      06/10/20055:29PMBusiness WireSchaeffer's Midday Options Update Features General Motors, Citigroup, Northrop Grumman, Intel, and Eyetech PharmaceuticalsNASDAQ:EYETEyetech Pharmaceuticals (MM)
      06/10/20058:31AMPR Newswire (US)Eyetech Announces Appointment of Henry Simon as Chairman of the Board and Resignation of John McLaughlinNASDAQ:EYETEyetech Pharmaceuticals (MM)
      06/09/20058:30AMPR Newswire (US)Eyetech Adopts Stockholder Rights AgreementNASDAQ:EYETEyetech Pharmaceuticals (MM)
      05/24/20059:30PMPR Newswire (US)Eyetech Announces Conference Call to Reiterate Confidence in Macugen(R) (Pegaptanib Sodium Injection)NASDAQ:EYETEyetech Pharmaceuticals (MM)
      05/24/20058:30AMPR Newswire (US)Eyetech Announces Approval of Macugen(R) in Brazil for the Treatment of Neovascular (Wet) Age-Related Macular DegenerationNASDAQ:EYETEyetech Pharmaceuticals (MM)
      05/10/20056:30PMPR Newswire (US)Eyetech to Present at the 2005 UBS Global Pharmaceuticals ConferenceNASDAQ:EYETEyetech Pharmaceuticals (MM)
      05/05/20055:10PMPR Newswire (US)Eyetech Announces Approval of Macugen(R) in Canada for The Treatment of Neovascular (Wet) Age Related Macular DegenerationNASDAQ:EYETEyetech Pharmaceuticals (MM)
      05/05/200510:19AMPR Newswire (US)Macugen(R) (pegaptanib sodium injection) Studied in Treatment of Diabetic Macular Edema (DME) and Other Diabetic Retinopathy LesNASDAQ:EYETEyetech Pharmaceuticals (MM)
      05/02/20055:10PMPR Newswire (US)Preclinical Study Demonstrates Significance of VEGF164 in Pathological NeovascularizationNASDAQ:EYETEyetech Pharmaceuticals (MM)
      05/02/20055:10PMPR Newswire (US)Safety Profile of Macugen(R) (pegaptanib sodium injection) in the Treatment of Neovascular Age-Related Macular Degeneration (AMDNASDAQ:EYETEyetech Pharmaceuticals (MM)
      04/21/20055:30PMPR Newswire (US)Eyetech to Present at Morgan Stanley's Third Annual Global Healthcare Unplugged ConferenceNASDAQ:EYETEyetech Pharmaceuticals (MM)
      04/20/20056:09PMPR Newswire (US)Eyetech Reports First Quarter 2005 Financial ResultsNASDAQ:EYETEyetech Pharmaceuticals (MM)
      04/07/20055:30PMPR Newswire (US)Eyetech Announces Co-Founder Marty Glick Steps Down From Board To Act As ConsultantNASDAQ:EYETEyetech Pharmaceuticals (MM)
      04/07/20055:30PMPR Newswire (US)Eyetech to Announce First Quarter 2005 Financial Results on April 20, 2005NASDAQ:EYETEyetech Pharmaceuticals (MM)
      03/18/20054:15PMPR Newswire (US)Eyetech to Present at the Eighth Annual Lehman Brothers Global Healthcare ConferenceNASDAQ:EYETEyetech Pharmaceuticals (MM)
       Showing the most relevant articles for your search:NASDAQ:EYET